Caldwell Trust Co Takes $450,000 Position in Lam Research Corporation $LRCX

Caldwell Trust Co purchased a new stake in Lam Research Corporation (NASDAQ:LRCX) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 4,620 shares of the semiconductor company’s stock, valued at approximately $450,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. IMG Wealth Management Inc. purchased a new position in shares of Lam Research in the second quarter worth approximately $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Lam Research in the 2nd quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC purchased a new position in Lam Research during the 2nd quarter worth approximately $29,000. Delos Wealth Advisors LLC purchased a new position in Lam Research during the 2nd quarter worth approximately $30,000. Finally, REAP Financial Group LLC acquired a new stake in Lam Research during the 2nd quarter valued at $31,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Trading Down 0.6%

NASDAQ:LRCX opened at $163.26 on Wednesday. The company has a market capitalization of $205.06 billion, a P/E ratio of 35.96, a P/E/G ratio of 1.69 and a beta of 1.77. The stock’s 50 day moving average price is $153.29 and its 200 day moving average price is $121.65. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $169.69.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s revenue for the quarter was up 27.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.6%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is 22.91%.

Insider Buying and Selling

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares of the company’s stock, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Ava Harter sold 9,010 shares of the stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the transaction, the insider directly owned 56,786 shares in the company, valued at approximately $8,942,091.42. This represents a 13.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 102,608 shares of company stock worth $14,916,496 over the last ninety days. 0.31% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. The Goldman Sachs Group lifted their price target on Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, October 8th. Dbs Bank lifted their target price on Lam Research from $119.40 to $184.20 in a research note on Monday, October 27th. UBS Group reiterated a “buy” rating and issued a $175.00 target price (up previously from $165.00) on shares of Lam Research in a report on Tuesday, November 25th. New Street Research raised their price target on shares of Lam Research from $105.00 to $140.00 and gave the stock a “neutral” rating in a report on Thursday, October 23rd. Finally, HSBC set a $127.00 price objective on shares of Lam Research and gave the company a “hold” rating in a research report on Tuesday, September 30th. Twenty-six research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat, Lam Research currently has an average rating of “Moderate Buy” and an average target price of $157.54.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.